Education
About Us
Working with TipRanks
Follow Us
Aurinia Pharmaceuticals (AUPH)
NASDAQ:AUPH
Aurinia Pharmaceuticals (AUPH) Ownership Overview
11.42% Insiders
4.69% Mutual Funds
17.09% Other Institutional Investors
6.95% ETFs
59.85% Public Companies and Individual Investors
The ownership structure of Aurinia Pharmaceuticals (AUPH) stock is a mix of institutional, retail, and individual investors. Approximately 28.73% of the company’s stock is owned by Institutional Investors, 11.42% is owned by Insiders, and 59.85% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Aug 05, 2025 | xxxxxxxxxxxxx | $13590000 | |
Aug 05, 2025 | xxxxxxxxxxxxx | $210000 | |
Mar 07, 2025 | xxxxxxxxxxxxx | $68350 | |
Mar 04, 2025 | xxxxxxxxxxxxx | $12713126 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 11,329,500 | Insider | 8.59% | 179,572,575 | |
| 5,490,361 | Institution | 4.16% | 87,022,222 | |
| 1,788,945 | Insider | 1.36% | 28,354,778 | |
| 1,520,774 | Institution | 1.15% | 24,104,268 | |
| 1,265,688 | Institution | 0.96% | 20,061,155 | |
| 1,205,216 | Institution | 0.91% | 19,102,674 | |
| 680,465 | Insider | 0.52% | 10,785,370 | |
| 665,428 | Institution | 0.50% | 10,547,034 | |
| 633,264 | Institution | 0.48% | 10,037,234 | |
| 577,361 | Insider | 0.44% | 9,151,172 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,520,774 | Institution | 1.15% | 24,104,268 | |
| 1,265,688 | Institution | 0.96% | 20,061,155 | |
| 665,428 | Institution | 0.50% | 10,547,034 | |
| 516,118 | Institution | 0.39% | 8,180,470 | |
| 346,870 | Institution | 0.26% | 5,497,890 | |
| 346,375 | Institution | 0.26% | 5,490,044 | |
| 190,459 | Institution | 0.14% | 3,018,775 | |
| 148,380 | Institution | 0.11% | 2,351,823 | |
| 130,000 | Institution | 0.10% | 2,060,500 | |
| 126,000 | Institution | 0.10% | 1,997,100 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,993,569 | Institution | 2.27% | 47,448,069 | |
| 1,036,855 | Institution | 0.79% | 16,434,152 | |
| 874,529 | Institution | 0.66% | 13,861,285 | |
| 562,832 | Institution | 0.43% | 7,412,497 | |
| 457,969 | Institution | 0.35% | 7,258,809 | |
| 347,500 | Institution | 0.26% | 4,576,575 | |
| 243,005 | Institution | 0.18% | 3,858,919 | |
| 205,992 | Institution | 0.16% | 3,271,153 | |
| 175,295 | Institution | 0.13% | 2,778,426 | |
| 108,203 | Institution | 0.08% | 1,718,264 |
FAQ
Who Owns Aurinia Pharmaceuticals (AUPH)?
According to the latest TipRanks data, approximately 17.09% of the company's stock is held by institutional investors, 11.42% is held by insiders, and 59.85% is held by retail investors.
What percentage of Aurinia Pharmaceuticals (AUPH) stock is held by institutional investors?
According to the latest TipRanks data, approximately 17.09% of Aurinia Pharmaceuticals (AUPH) stock is held by institutional investors.
What percentage of Aurinia Pharmaceuticals (AUPH) stock is held by retail investors?
According to the latest TipRanks data, approximately 59.85% of Aurinia Pharmaceuticals (AUPH) stock is held by retail investors.
Who owns the most shares of Aurinia Pharmaceuticals (AUPH)?
Kevin Tang owns the most shares of Aurinia Pharmaceuticals (AUPH).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.